Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exogenous KETOne Supplements in Patients Hospitalized for Acute Heart Failure. A Randomized Clinical Trial (KETO-AHF)

NCT06653725 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT06653725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06653725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exogenous KETOne Supplements in Patients Hospitalized for Acute Heart Failure. A Randomized Clinical Trial (KETO-AHF)
Lead sponsor
Aarhus University Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
March 20, 2025
Completion date
January 1, 2028
Enrollment
250 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure (ahf)